820 | PHASE 2 STUDY OF DZD8586, A NON‐COVALENT BBB PENETRANT LYN/BTK DUAL INHIBITOR, AS MONOTHERAPY IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: TAI‐SHAN9 TRIAL Article Swipe
Lugui Qiu
,
Yanling Li
,
Keshu Zhou
,
Ming Jiang
,
Wei Liu
,
Zhilin Li
,
Min Zheng
,
Zhilin Li
,
Wenbin Qian
,
Minhuan Lan
,
Pengcheng He
,
Ke Ding
,
Fang Zhu
,
Hongmei Jing
,
Z. Liu
,
Lihua Qiu
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1002/hon.70096_820
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1002/hon.70096_820
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/hon.70096_820
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70096_820
- OA Status
- bronze
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4411323591
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4411323591Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/hon.70096_820Digital Object Identifier
- Title
-
820 | PHASE 2 STUDY OF DZD8586, A NON‐COVALENT BBB PENETRANT LYN/BTK DUAL INHIBITOR, AS MONOTHERAPY IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: TAI‐SHAN9 TRIALWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-06-01Full publication date if available
- Authors
-
Lugui Qiu, Yanling Li, Keshu Zhou, Ming Jiang, Wei Liu, Zhilin Li, Min Zheng, Zhilin Li, Wenbin Qian, Minhuan Lan, Pengcheng He, Ke Ding, Fang Zhu, Hongmei Jing, Z. Liu, Lihua QiuList of authors in order
- Landing page
-
https://doi.org/10.1002/hon.70096_820Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70096_820Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70096_820Direct OA link when available
- Concepts
-
LYN, Bruton's tyrosine kinase, Refractory (planetary science), Penetrant (biochemical), Medicine, Ibrutinib, Cancer research, Dermatology, Pharmacology, Internal medicine, Chronic lymphocytic leukemia, Materials science, Leukemia, Chemistry, Tyrosine kinase, Composite material, Organic chemistry, ReceptorTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4411323591 |
|---|---|
| doi | https://doi.org/10.1002/hon.70096_820 |
| ids.doi | https://doi.org/10.1002/hon.70096_820 |
| ids.openalex | https://openalex.org/W4411323591 |
| fwci | 0.0 |
| type | article |
| title | 820 | PHASE 2 STUDY OF DZD8586, A NON‐COVALENT BBB PENETRANT LYN/BTK DUAL INHIBITOR, AS MONOTHERAPY IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: TAI‐SHAN9 TRIAL |
| biblio.issue | S3 |
| biblio.volume | 43 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11491 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9975000023841858 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | CAR-T cell therapy research |
| topics[1].id | https://openalex.org/T11157 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9936000108718872 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2716 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Chronic Lymphocytic Leukemia Research |
| topics[2].id | https://openalex.org/T10185 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.992900013923645 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2734 |
| topics[2].subfield.display_name | Pathology and Forensic Medicine |
| topics[2].display_name | Lymphoma Diagnosis and Treatment |
| is_xpac | False |
| apc_list.value | 4220 |
| apc_list.currency | USD |
| apc_list.value_usd | 4220 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C175818844 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9041050672531128 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q2463389 |
| concepts[0].display_name | LYN |
| concepts[1].id | https://openalex.org/C90059517 |
| concepts[1].level | 4 |
| concepts[1].score | 0.7399896383285522 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q423572 |
| concepts[1].display_name | Bruton's tyrosine kinase |
| concepts[2].id | https://openalex.org/C142424586 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6742817759513855 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q7307572 |
| concepts[2].display_name | Refractory (planetary science) |
| concepts[3].id | https://openalex.org/C2779335537 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5914630889892578 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7162617 |
| concepts[3].display_name | Penetrant (biochemical) |
| concepts[4].id | https://openalex.org/C71924100 |
| concepts[4].level | 0 |
| concepts[4].score | 0.5311709046363831 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[4].display_name | Medicine |
| concepts[5].id | https://openalex.org/C2779878957 |
| concepts[5].level | 4 |
| concepts[5].score | 0.4576188623905182 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q5984881 |
| concepts[5].display_name | Ibrutinib |
| concepts[6].id | https://openalex.org/C502942594 |
| concepts[6].level | 1 |
| concepts[6].score | 0.3931572437286377 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[6].display_name | Cancer research |
| concepts[7].id | https://openalex.org/C16005928 |
| concepts[7].level | 1 |
| concepts[7].score | 0.35738176107406616 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q171171 |
| concepts[7].display_name | Dermatology |
| concepts[8].id | https://openalex.org/C98274493 |
| concepts[8].level | 1 |
| concepts[8].score | 0.32560810446739197 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[8].display_name | Pharmacology |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.2640063166618347 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| concepts[10].id | https://openalex.org/C2777938653 |
| concepts[10].level | 3 |
| concepts[10].score | 0.22552821040153503 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1088156 |
| concepts[10].display_name | Chronic lymphocytic leukemia |
| concepts[11].id | https://openalex.org/C192562407 |
| concepts[11].level | 0 |
| concepts[11].score | 0.21739041805267334 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q228736 |
| concepts[11].display_name | Materials science |
| concepts[12].id | https://openalex.org/C2778461978 |
| concepts[12].level | 2 |
| concepts[12].score | 0.1873047649860382 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q29496 |
| concepts[12].display_name | Leukemia |
| concepts[13].id | https://openalex.org/C185592680 |
| concepts[13].level | 0 |
| concepts[13].score | 0.18386521935462952 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[13].display_name | Chemistry |
| concepts[14].id | https://openalex.org/C42362537 |
| concepts[14].level | 3 |
| concepts[14].score | 0.07874900102615356 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q87099740 |
| concepts[14].display_name | Tyrosine kinase |
| concepts[15].id | https://openalex.org/C159985019 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q181790 |
| concepts[15].display_name | Composite material |
| concepts[16].id | https://openalex.org/C178790620 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q11351 |
| concepts[16].display_name | Organic chemistry |
| concepts[17].id | https://openalex.org/C170493617 |
| concepts[17].level | 2 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[17].display_name | Receptor |
| keywords[0].id | https://openalex.org/keywords/lyn |
| keywords[0].score | 0.9041050672531128 |
| keywords[0].display_name | LYN |
| keywords[1].id | https://openalex.org/keywords/brutons-tyrosine-kinase |
| keywords[1].score | 0.7399896383285522 |
| keywords[1].display_name | Bruton's tyrosine kinase |
| keywords[2].id | https://openalex.org/keywords/refractory |
| keywords[2].score | 0.6742817759513855 |
| keywords[2].display_name | Refractory (planetary science) |
| keywords[3].id | https://openalex.org/keywords/penetrant |
| keywords[3].score | 0.5914630889892578 |
| keywords[3].display_name | Penetrant (biochemical) |
| keywords[4].id | https://openalex.org/keywords/medicine |
| keywords[4].score | 0.5311709046363831 |
| keywords[4].display_name | Medicine |
| keywords[5].id | https://openalex.org/keywords/ibrutinib |
| keywords[5].score | 0.4576188623905182 |
| keywords[5].display_name | Ibrutinib |
| keywords[6].id | https://openalex.org/keywords/cancer-research |
| keywords[6].score | 0.3931572437286377 |
| keywords[6].display_name | Cancer research |
| keywords[7].id | https://openalex.org/keywords/dermatology |
| keywords[7].score | 0.35738176107406616 |
| keywords[7].display_name | Dermatology |
| keywords[8].id | https://openalex.org/keywords/pharmacology |
| keywords[8].score | 0.32560810446739197 |
| keywords[8].display_name | Pharmacology |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.2640063166618347 |
| keywords[9].display_name | Internal medicine |
| keywords[10].id | https://openalex.org/keywords/chronic-lymphocytic-leukemia |
| keywords[10].score | 0.22552821040153503 |
| keywords[10].display_name | Chronic lymphocytic leukemia |
| keywords[11].id | https://openalex.org/keywords/materials-science |
| keywords[11].score | 0.21739041805267334 |
| keywords[11].display_name | Materials science |
| keywords[12].id | https://openalex.org/keywords/leukemia |
| keywords[12].score | 0.1873047649860382 |
| keywords[12].display_name | Leukemia |
| keywords[13].id | https://openalex.org/keywords/chemistry |
| keywords[13].score | 0.18386521935462952 |
| keywords[13].display_name | Chemistry |
| keywords[14].id | https://openalex.org/keywords/tyrosine-kinase |
| keywords[14].score | 0.07874900102615356 |
| keywords[14].display_name | Tyrosine kinase |
| language | en |
| locations[0].id | doi:10.1002/hon.70096_820 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S23714410 |
| locations[0].source.issn | 0278-0232, 1099-1069 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0278-0232 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Hematological Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_lineage_names | Wiley |
| locations[0].license | |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70096_820 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Hematological Oncology |
| locations[0].landing_page_url | https://doi.org/10.1002/hon.70096_820 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5017804632 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8752-0644 |
| authorships[0].author.display_name | Lugui Qiu |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I200296433, https://openalex.org/I4210147887 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Lymphoma and Myeloma Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin China |
| authorships[0].institutions[0].id | https://openalex.org/I200296433 |
| authorships[0].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[0].institutions[1].id | https://openalex.org/I4210147887 |
| authorships[0].institutions[1].ror | https://ror.org/04n16t016 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210147887 |
| authorships[0].institutions[1].country_code | CN |
| authorships[0].institutions[1].display_name | Institute of Hematology & Blood Diseases Hospital |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | L. Qiu |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Lymphoma and Myeloma Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin China |
| authorships[1].author.id | https://openalex.org/A5100363321 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-2007-9716 |
| authorships[1].author.display_name | Yanling Li |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210115624 |
| authorships[1].affiliations[0].raw_affiliation_string | Hunan Cancer Hospital Changsha China |
| authorships[1].institutions[0].id | https://openalex.org/I4210115624 |
| authorships[1].institutions[0].ror | https://ror.org/025020z88 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210115624 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | Hunan Cancer Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Y. Li |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Hunan Cancer Hospital Changsha China |
| authorships[2].author.id | https://openalex.org/A5050450526 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-5467-1377 |
| authorships[2].author.display_name | Keshu Zhou |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210143608 |
| authorships[2].affiliations[0].raw_affiliation_string | Henan Cancer Hospital Zhengzhou China |
| authorships[2].institutions[0].id | https://openalex.org/I4210143608 |
| authorships[2].institutions[0].ror | https://ror.org/043ek5g31 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210143608 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Henan Cancer Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | K. Zhou |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Henan Cancer Hospital Zhengzhou China |
| authorships[3].author.id | https://openalex.org/A5100774351 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1417-360X |
| authorships[3].author.display_name | Ming Jiang |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I24185976, https://openalex.org/I4210089761 |
| authorships[3].affiliations[0].raw_affiliation_string | West China Hospital Chengdu China |
| authorships[3].institutions[0].id | https://openalex.org/I24185976 |
| authorships[3].institutions[0].ror | https://ror.org/011ashp19 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I24185976 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Sichuan University |
| authorships[3].institutions[1].id | https://openalex.org/I4210089761 |
| authorships[3].institutions[1].ror | https://ror.org/007mrxy13 |
| authorships[3].institutions[1].type | healthcare |
| authorships[3].institutions[1].lineage | https://openalex.org/I4210089761 |
| authorships[3].institutions[1].country_code | CN |
| authorships[3].institutions[1].display_name | West China Hospital of Sichuan University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | M. Jiang |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | West China Hospital Chengdu China |
| authorships[4].author.id | https://openalex.org/A5100431863 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-7908-8476 |
| authorships[4].author.display_name | Wei Liu |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I200296433, https://openalex.org/I4210147887 |
| authorships[4].affiliations[0].raw_affiliation_string | State Key Laboratory of Experimental Hematology National Clinical Research Center for Blood Diseases Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin China |
| authorships[4].institutions[0].id | https://openalex.org/I200296433 |
| authorships[4].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[4].institutions[1].id | https://openalex.org/I4210147887 |
| authorships[4].institutions[1].ror | https://ror.org/04n16t016 |
| authorships[4].institutions[1].type | healthcare |
| authorships[4].institutions[1].lineage | https://openalex.org/I4210147887 |
| authorships[4].institutions[1].country_code | CN |
| authorships[4].institutions[1].display_name | Institute of Hematology & Blood Diseases Hospital |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | W. Liu |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | State Key Laboratory of Experimental Hematology National Clinical Research Center for Blood Diseases Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin China |
| authorships[5].author.id | https://openalex.org/A5101930655 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-1636-5376 |
| authorships[5].author.display_name | Zhilin Li |
| authorships[5].countries | CN |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I157773358, https://openalex.org/I4210146711 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Lymphoma Medicine Sun Yat‐sen University Cancer Center Guangzhou China |
| authorships[5].institutions[0].id | https://openalex.org/I157773358 |
| authorships[5].institutions[0].ror | https://ror.org/0064kty71 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I157773358 |
| authorships[5].institutions[0].country_code | CN |
| authorships[5].institutions[0].display_name | Sun Yat-sen University |
| authorships[5].institutions[1].id | https://openalex.org/I4210146711 |
| authorships[5].institutions[1].ror | https://ror.org/0400g8r85 |
| authorships[5].institutions[1].type | healthcare |
| authorships[5].institutions[1].lineage | https://openalex.org/I4210146711 |
| authorships[5].institutions[1].country_code | CN |
| authorships[5].institutions[1].display_name | Sun Yat-sen University Cancer Center |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Z. Li |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Lymphoma Medicine Sun Yat‐sen University Cancer Center Guangzhou China |
| authorships[6].author.id | https://openalex.org/A5100706460 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-5333-8166 |
| authorships[6].author.display_name | Min Zheng |
| authorships[6].affiliations[0].raw_affiliation_string | Linyi Cancer Hospital Linyi China |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | M. Zheng |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Linyi Cancer Hospital Linyi China |
| authorships[7].author.id | https://openalex.org/A5101930655 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-1636-5376 |
| authorships[7].author.display_name | Zhilin Li |
| authorships[7].countries | CN |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210100830, https://openalex.org/I4210163399 |
| authorships[7].affiliations[0].raw_affiliation_string | Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan China |
| authorships[7].institutions[0].id | https://openalex.org/I4210163399 |
| authorships[7].institutions[0].ror | https://ror.org/05jb9pq57 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210163399 |
| authorships[7].institutions[0].country_code | CN |
| authorships[7].institutions[0].display_name | Shandong First Medical University |
| authorships[7].institutions[1].id | https://openalex.org/I4210100830 |
| authorships[7].institutions[1].ror | https://ror.org/01413r497 |
| authorships[7].institutions[1].type | healthcare |
| authorships[7].institutions[1].lineage | https://openalex.org/I4210100830 |
| authorships[7].institutions[1].country_code | CN |
| authorships[7].institutions[1].display_name | Shandong Tumor Hospital |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Z. Li |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan China |
| authorships[8].author.id | https://openalex.org/A5101807840 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-9817-6674 |
| authorships[8].author.display_name | Wenbin Qian |
| authorships[8].countries | CN |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210158318 |
| authorships[8].affiliations[0].raw_affiliation_string | The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China |
| authorships[8].institutions[0].id | https://openalex.org/I4210158318 |
| authorships[8].institutions[0].ror | https://ror.org/059cjpv64 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210158318 |
| authorships[8].institutions[0].country_code | CN |
| authorships[8].institutions[0].display_name | Second Affiliated Hospital of Zhejiang University |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | W. Qian |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China |
| authorships[9].author.id | https://openalex.org/A5000647728 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-9492-2115 |
| authorships[9].author.display_name | Minhuan Lan |
| authorships[9].countries | CN |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210115919 |
| authorships[9].affiliations[0].raw_affiliation_string | The People's Hospital of Guangxi Zhuang Autonomous Region Nanning China |
| authorships[9].institutions[0].id | https://openalex.org/I4210115919 |
| authorships[9].institutions[0].ror | https://ror.org/02aa8kj12 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210115919 |
| authorships[9].institutions[0].country_code | CN |
| authorships[9].institutions[0].display_name | The People's Hospital of Guangxi Zhuang Autonomous Region |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | M. Lan |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | The People's Hospital of Guangxi Zhuang Autonomous Region Nanning China |
| authorships[10].author.id | https://openalex.org/A5056538208 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-9531-531X |
| authorships[10].author.display_name | Pengcheng He |
| authorships[10].countries | CN |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210121771 |
| authorships[10].affiliations[0].raw_affiliation_string | First Affiliated Hospital of Xi'an Jiaotong University Xian China |
| authorships[10].institutions[0].id | https://openalex.org/I4210121771 |
| authorships[10].institutions[0].ror | https://ror.org/02tbvhh96 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210121771 |
| authorships[10].institutions[0].country_code | CN |
| authorships[10].institutions[0].display_name | First Affiliated Hospital of Xi'an Jiaotong University |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | P. He |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | First Affiliated Hospital of Xi'an Jiaotong University Xian China |
| authorships[11].author.id | https://openalex.org/A5001466305 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-9016-812X |
| authorships[11].author.display_name | Ke Ding |
| authorships[11].affiliations[0].raw_affiliation_string | The First Affiliated Hospital of USTC Hefei China |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | K. Ding |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | The First Affiliated Hospital of USTC Hefei China |
| authorships[12].author.id | https://openalex.org/A5085766566 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-6676-1270 |
| authorships[12].author.display_name | Fang Zhu |
| authorships[12].countries | CN |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210129222 |
| authorships[12].affiliations[0].raw_affiliation_string | Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China |
| authorships[12].institutions[0].id | https://openalex.org/I4210129222 |
| authorships[12].institutions[0].ror | https://ror.org/0371fqr87 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210129222 |
| authorships[12].institutions[0].country_code | CN |
| authorships[12].institutions[0].display_name | Wuhan Union Hospital |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | F. Zhu |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China |
| authorships[13].author.id | https://openalex.org/A5089850088 |
| authorships[13].author.orcid | https://orcid.org/0000-0003-4958-2489 |
| authorships[13].author.display_name | Hongmei Jing |
| authorships[13].countries | CN |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I20231570, https://openalex.org/I4210141942 |
| authorships[13].affiliations[0].raw_affiliation_string | Peking University Third Hospital Beijing China |
| authorships[13].institutions[0].id | https://openalex.org/I20231570 |
| authorships[13].institutions[0].ror | https://ror.org/02v51f717 |
| authorships[13].institutions[0].type | education |
| authorships[13].institutions[0].lineage | https://openalex.org/I20231570 |
| authorships[13].institutions[0].country_code | CN |
| authorships[13].institutions[0].display_name | Peking University |
| authorships[13].institutions[1].id | https://openalex.org/I4210141942 |
| authorships[13].institutions[1].ror | https://ror.org/04wwqze12 |
| authorships[13].institutions[1].type | healthcare |
| authorships[13].institutions[1].lineage | https://openalex.org/I4210141942 |
| authorships[13].institutions[1].country_code | CN |
| authorships[13].institutions[1].display_name | Peking University Third Hospital |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | H. Jing |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Peking University Third Hospital Beijing China |
| authorships[14].author.id | https://openalex.org/A5048519918 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Z. Liu |
| authorships[14].affiliations[0].raw_affiliation_string | Dizal Pharmaceutical Co., Ltd Shanghai China |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Z. Liu |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Dizal Pharmaceutical Co., Ltd Shanghai China |
| authorships[15].author.id | https://openalex.org/A5001135284 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-4637-1811 |
| authorships[15].author.display_name | Lihua Qiu |
| authorships[15].countries | CN |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I2802573037 |
| authorships[15].affiliations[0].raw_affiliation_string | Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital Tianjin China |
| authorships[15].institutions[0].id | https://openalex.org/I2802573037 |
| authorships[15].institutions[0].ror | https://ror.org/0152hn881 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I2802573037 |
| authorships[15].institutions[0].country_code | CN |
| authorships[15].institutions[0].display_name | Tianjin Medical University Cancer Institute and Hospital |
| authorships[15].author_position | last |
| authorships[15].raw_author_name | L. Qiu |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital Tianjin China |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70096_820 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | 820 | PHASE 2 STUDY OF DZD8586, A NON‐COVALENT BBB PENETRANT LYN/BTK DUAL INHIBITOR, AS MONOTHERAPY IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: TAI‐SHAN9 TRIAL |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11491 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9975000023841858 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | CAR-T cell therapy research |
| related_works | https://openalex.org/W1830209188, https://openalex.org/W2121548526, https://openalex.org/W2990290302, https://openalex.org/W3083764575, https://openalex.org/W3133876073, https://openalex.org/W2981016883, https://openalex.org/W2512656347, https://openalex.org/W2614001962, https://openalex.org/W4249624647, https://openalex.org/W1999824748 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1002/hon.70096_820 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S23714410 |
| best_oa_location.source.issn | 0278-0232, 1099-1069 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0278-0232 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Hematological Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_lineage_names | Wiley |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70096_820 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Hematological Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.1002/hon.70096_820 |
| primary_location.id | doi:10.1002/hon.70096_820 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S23714410 |
| primary_location.source.issn | 0278-0232, 1099-1069 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0278-0232 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Hematological Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_lineage_names | Wiley |
| primary_location.license | |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70096_820 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Hematological Oncology |
| primary_location.landing_page_url | https://doi.org/10.1002/hon.70096_820 |
| publication_date | 2025-06-01 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 16 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.44999998807907104 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.33261279 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |